List of insiders holdings for SELLAS Life Sciences Group Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Hudson Bay Capital Management LP Gerber Sander 10% Owner | 2017-02-10 18:16:17 | 0 2,037,659 | 2,037,659 | Form 4 |
| Kennedy Robert Eugene Vice President and CFO | 2011-04-22 11:56:37 | 404,288 379,294 | 783,582 | Form 4 |
| Lopez Fabio EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund` Equilibria Capital Management Ltd Castilian Ltd. Varibobi Financial Holdings Ltd Tafur Daniel EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund Former Director, 10% holder Director | 2018-10-09 18:51:04 | 673,671 0 | 673,671 | Form 13D |
| Stergiou Angelos M. President and CEO | 2024-01-25 06:04:41 | 614,921 0 | 614,921 | Form 4 |
| MAZANET ROSEMARY Chief Medical Officer | 2013-01-31 18:24:03 | 450,000 0 | 450,000 | Form 4 |
| SCHWARTZ MARK W. President & CEO | 2016-07-06 17:23:17 | 448,481 0 | 448,481 | Form 4 |
| Woolf Tod President and CEO | 2009-01-20 19:15:27 | 420,100 0 | 420,100 | Form 4 |
| CICIC DRAGAN SVP, Chief Development Officer | 2024-06-27 16:10:06 | 369,584 0 | 369,584 | Form 3 |
| DiPalma Stephen J. CFO, EVP, Secretary | 2009-01-20 19:12:48 | 369,074 0 | 369,074 | Form 4 |
| Burns John Thomas CFO | 2024-01-25 06:00:13 | 176,927 0 | 176,927 | Form 4 |
| WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. | 2024-01-25 06:03:53 | 167,225 0 | 167,225 | Form 4 |
| Pavco Pamela Former VP Pharma Development | 2011-09-27 21:57:05 | 150,000 0 | 150,000 | Form 4 |
| Dunlap Ryan Former Chief Financial Officer | 2016-06-07 18:36:24 | 144,327 0 | 144,327 | Form 4 |
| Khvorova Anastasia Former CSO | 2011-09-27 21:01:58 | 137,482 0 | 137,482 | Form 4 |
| Ahn Mark J President & CEO | 2014-09-19 14:27:25 | 116,225 0 | 116,225 | Form 4/A |
| KRIEGSMAN STEVEN A Director | 2015-06-23 20:44:33 | 100,000 0 | 100,000 | Form 4 |
| Beerman Noah D CEO and President | 2011-03-17 20:08:02 | 92,994 0 | 92,994 | Form 4 |
| Francomano Robert Chief Commercial Officer | 2024-01-25 06:02:10 | 70,918 0 | 70,918 | Form 4 |
| Hillsberg Sanford Director | 2017-10-10 17:56:56 | 56,950 0 | 56,950 | Form 4 |
| Kivinski Margaret VP and General Counsel | 2015-01-20 19:17:44 | 50,000 0 | 50,000 | Form 4 |
| Sarlis Nicholas J. Chief Medical Officer and SVP | 2019-03-18 19:03:32 | 50,000 0 | 50,000 | Form 4 |
| Nisi Rudolph Director | 2017-10-10 18:01:29 | 42,918 0 | 42,918 | Form 4 |
| Varanasi Ramani VP Business Development | 2011-03-17 20:18:41 | 41,083 0 | 41,083 | Form 4 |
| Mack Gene CFO and Treasurer | 2018-04-24 16:53:27 | 40,000 0 | 40,000 | Form 4 |
| GRAY MARY ANN Director | 2017-10-10 17:59:12 | 39,167 0 | 39,167 | Form 4 |
| Ashton William Director | 2017-10-10 17:48:56 | 38,154 0 | 38,154 | Form 4 |
| GALLIKER STEPHEN S Director | 2017-10-10 17:54:27 | 36,039 0 | 36,039 | Form 4 |
| Einhorn Irving M. Director | 2017-10-10 17:51:15 | 34,690 0 | 34,690 | Form 4 |
| Chin Richard Director | 2017-10-10 17:45:21 | 31,339 0 | 31,339 | Form 4 |
| Torre Gregory M CRO and SVP | 2018-03-15 19:58:21 | 30,000 0 | 30,000 | Form 4 |
| Nejadnik Bijan Chief Medical Officer | 2017-01-19 19:44:10 | 30,000 0 | 30,000 | Form 4 |
| Ghiglieri Stephen F Director | 2019-03-18 19:03:09 | 25,000 0 | 25,000 | Form 4 |
| SCHEINBERG DAVID A Director | 2024-01-25 06:03:57 | 20,582 0 | 20,582 | Form 4 |
| VAN NOSTRAND ROBERT L Director | 2024-01-25 06:00:16 | 20,400 0 | 20,400 | Form 4 |
| Varian John Director | 2024-01-25 06:01:38 | 20,400 0 | 20,400 | Form 4 |
| Wasman Jane Director | 2024-01-25 06:02:26 | 20,400 0 | 20,400 | Form 4 |
| Kalin Katherine Bach Director | 2024-01-25 06:03:06 | 18,500 0 | 18,500 | Form 4 |
| Andrikopoulos Konstantinos VP, Legal | 2010-04-16 18:04:36 | 15,000 0 | 15,000 | Form 4 |
| Tata Amy B Principlw Acctg Officer & Cont | 2011-03-17 20:16:11 | 14,065 0 | 14,065 | Form 4 |
| Knapp Thomas J General Counsel | 2017-02-07 16:58:46 | 10,000 0 | 10,000 | Form 4 |
| Lee Kwang Principal Accounting Officer | 2011-12-07 16:39:11 | 5,000 0 | 5,000 | Form 4 |
| HAMILTON BRIAN L EVP, Chief Medical Officer | 2014-07-02 14:25:53 | 4,922 0 | 4,922 | Form 4 |
| Krylov Aleksey N. Interim CFO | 2017-12-29 17:00:57 | 0 0 | 0 | Form 3 |
| CYTRX CORP 10% Owner | 2011-02-09 11:53:36 | 0 0 | 0 | Form 13G |
| Samarsky Dmitry VP, Technology Development | 2010-04-02 09:59:02 | 0 0 | 0 | Form 4 |